Greenleaf Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Sell
14,848
-493
-3% -$47.2K 0.01% 281
2025
Q4
$1.47M Buy
15,341
+865
+6% +$84K 0.01% 249
2025
Q3
$1.38M Buy
14,476
+1,117
+8% +$103K 0.01% 258
2025
Q2
$1.16M Sell
13,359
-7,920
-37% -$672K 0.01% 288
2025
Q1
$1.91M Buy
21,279
+7,184
+51% +$643K 0.02% 208
2024
Q4
$1.13M Buy
14,095
+1,174
+9% +$102K 0.01% 296
2024
Q3
$1.16M Sell
12,921
-3,898
-23% -$328K 0.01% 297
2024
Q2
$1.32M Buy
16,819
+2,228
+15% +$183K 0.01% 251
2024
Q1
$1.27M Buy
14,591
+6,135
+73% +$524K 0.01% 255
2023
Q4
$697K Sell
8,456
-11,271
-57% -$859K 0.01% 369
2023
Q3
$1.55M Sell
19,727
-1,841
-9% -$154K 0.02% 196
2023
Q2
$1.9M Sell
21,568
-2,019
-9% -$174K 0.02% 169
2023
Q1
$1.9M Buy
23,587
+10,824
+85% +$882K 0.02% 165
2022
Q4
$992K Sell
12,763
-8,393
-40% -$680K 0.01% 270
2022
Q3
$1.71M Buy
21,156
+5,186
+32% +$466K 0.03% 168
2022
Q2
$1.43M Sell
15,970
-4,486
-22% -$455K 0.02% 169
2022
Q1
$2.27M Buy
20,456
+1,203
+6% +$127K 0.03% 125
2021
Q4
$1.99M Sell
19,253
-3,651
-16% -$423K 0.02% 139
2021
Q3
$2.87M Buy
22,904
+1,353
+6% +$175K 0.04% 92
2021
Q2
$2.67M Buy
21,551
+974
+5% +$122K 0.03% 101
2021
Q1
$2.43M Buy
20,577
+3,702
+22% +$434K 0.03% 102
2020
Q4
$1.98M Buy
16,875
+681
+4% +$75K 0.03% 110
2020
Q3
$1.68M Buy
16,194
+948
+6% +$95.2K 0.03% 115
2020
Q2
$1.4M Buy
15,246
+4,327
+40% +$415K 0.02% 124
2020
Q1
$985K Sell
10,919
-4,473
-29% -$476K 0.02% 135
2019
Q4
$1.75M Buy
15,392
+2,554
+20% +$280K 0.03% 111
2019
Q3
$1.39M Buy
12,838
+1,468
+13% +$153K 0.02% 126
2019
Q2
$1.11M Buy
11,370
+1,156
+11% +$106K 0.02% 155
2019
Q1
$930K Sell
10,214
-2,605
-20% -$233K 0.02% 170
2018
Q4
$1.17M Buy
12,819
+1,688
+15% +$158K 0.02% 137
2018
Q3
$1.09M Buy
11,131
+763
+7% +$70.5K 0.02% 161
2018
Q2
$888K Buy
10,368
+4,945
+91% +$413K 0.02% 173
2018
Q1
$435K Buy
5,423
+997
+23% +$82.2K 0.01% 262
2017
Q4
$357K Buy
4,426
+3,358
+314% +$269K 0.01% 300
2017
Q3
$83K Buy
+1,068
New +$88.7K ﹤0.01% 410
2017
Q1
Sell
-3,247
Closed -$231K 325
2016
Q4
$231K Buy
3,247
+718
+28% +$56.4K 0.01% 211
2016
Q3
$219K Buy
+2,529
New +$220K 0.01% 190

Other funds holding MDT

Greenleaf Trust's MDT Position: Q1 2026 in Review

Greenleaf Trust reduced its Medtronic (MDT) stake by 3.2% in Q1 2026, selling an estimated $47.2K and leaving 14,848 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #281.

Greenleaf Trust first reported a position in MDT in Q3 2016 and has held it in 37 quarters since. The position peaked at $2.87M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Greenleaf Trust held 14,848 shares of Medtronic worth $1.29M as of Q1 2026.
  • Greenleaf Trust sold 493 Medtronic shares in Q1 2026, an estimated $47.2K.
  • Medtronic made up 0.01% of Greenleaf Trust's portfolio in Q1 2026, its #281 holding.
  • Greenleaf Trust first reported a position in Medtronic in Q3 2016 and has held it in 37 quarters since.
  • Greenleaf Trust's Medtronic position peaked at $2.87M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.